Trans-Vaccenic acid-d13
Trans-Vaccenic acid-d13 is deuterium labeled trans-Vaccenic acid. trans-Vaccenic acid is a naturally occurring trans fatty acid (TFA). trans-Vaccenic acid inhibits nasopharyngeal carcinoma (NPC) cell growth and induces apoptosis through the inhibition of Bad/Akt phosphorylation. trans-Vaccenic acid is a precursor for the synthesis of saturated fatty acid in the rumen and of conjugated Linoleic acid (CLA) at the tissue level. trans-Vaccenic acid exerts hypolipidemic effects in a rat model of obesity[1][2][3][4].
Product Specifications
UNSPSC
12352211
Target
Apoptosis; Bcl-2 Family; Endogenous Metabolite; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Apoptosis; Metabolic Enzyme/Protease; Others
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Cardiovascular Disease
Smiles
OC(CCCCCCCCC/C=C/C([2H])(C([2H])(C([2H])(C([2H])(C(C([2H])([2H])[2H])([2H])[2H])[2H])[2H])[2H])[2H])=O
Molecular Formula
C18H21D13O2
Molecular Weight
295.54
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 8/18 (C-51), CF594 conjugate, 0.1mg/mL
UPK3A (Uroplakin 3A) (Rabbit PAb), CF647 conjugate, 0.1mg/mL
